BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30788749)

  • 1. Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.
    Takayoshi K; Kusaba H; Aikawa T; Koreishi S; Sagara K; Nakano M; Komoda M; Kono M; Fukata M; Arita T; Esaki T; Akashi K; Baba E
    Gastric Cancer; 2019 Sep; 22(5):988-998. PubMed ID: 30788749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience.
    Kang MJ; Ryoo BY; Ryu MH; Koo DH; Chang HM; Lee JL; Kim TW; Kang YK
    Eur J Cancer; 2012 Mar; 48(4):492-500. PubMed ID: 22169121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
    Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
    Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Oral Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism in Routine Clinical Practice.
    Ogino Y; Ishigami T; Minamimoto Y; Kimura Y; Akiyama E; Okada K; Matsuzawa Y; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Ishikawa T; Tamura K; Kimura K
    Circ J; 2020 Jul; 84(8):1330-1338. PubMed ID: 32624519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants.
    Ay C; Beyer-Westendorf J; Pabinger I
    Ann Oncol; 2019 Jun; 30(6):897-907. PubMed ID: 30918939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
    Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
    Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism.
    Gon Y; Sakaguchi M; Takasugi J; Mochizuki H
    Thromb Res; 2017 Jun; 154():16-18. PubMed ID: 28384442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of direct oral anti-coagulants for the treatment of venous thromboembolism in patients with advanced cancer: a prospective observational study.
    Oyakawa T; Muraoka N; Iida K; Kusuhara M; Mori K
    Int J Clin Oncol; 2019 Jul; 24(7):876-881. PubMed ID: 30756270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Ross JA; Miller MM; Rojas Hernandez CM
    Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.
    Rollins KE; Peters CJ; Safranek PM; Ford H; Baglin TP; Hardwick RH
    Eur J Surg Oncol; 2011 Dec; 37(12):1072-7. PubMed ID: 21925829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative incidence, risk factors and prognostic impact of venous thromboembolism in Japanese patients with advanced gastric cancer.
    Arai H; Hironaka S; Minashi K; Denda T; Shimokawa M; Yamaguchi T
    Jpn J Clin Oncol; 2017 Oct; 47(10):942-948. PubMed ID: 28981740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study.
    Bang SM; Kang JH; Hong MH; Ahn JS; Oh SY; Baek JH; Choi YJ; Shin SH; Kim YJ; Gil HY; Park HE; Lee J; Park EL
    Clin Appl Thromb Hemost; 2021; 27():1076029620979575. PubMed ID: 33471574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolism.
    Kelley D; Wright L; Ohman K; Ferreira J
    J Thromb Thrombolysis; 2018 Jul; 46(1):58-61. PubMed ID: 29797208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism.
    Verso M; Munoz A; Bauersachs R; Huisman MV; Mandalà M; Vescovo G; Becattini C; Agnelli G
    Eur J Cancer; 2021 May; 148():371-381. PubMed ID: 33780665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of direct oral anticoagulants vs. low molecular weight heparin for cancer-related venous thromboembolism: a meta-analysis of randomized trials.
    Elbadawi A; Shnoda M; Mahmoud K; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):380-388. PubMed ID: 32556105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV
    Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.
    Patel A; Williams H; Baer MR; Zimrin AB; Law JY
    Acta Haematol; 2019; 142(4):233-238. PubMed ID: 31108496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
    Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct oral anticoagulants in patients with hematologic malignancies.
    Serrao A; Fiori L; Santoro C; De Luca ML; Ferretti A; De Luca G; Ligia S; Lapietra G; Mohamed S; Breccia M; Chistolini A
    Hematol Oncol; 2020 Oct; 38(4):589-596. PubMed ID: 32588912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.